Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 0 · FY2022 0 · FY2023 0
Georgian pharmacy/pharmaceutical distribution company.
Subsidiary of Epa (90.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 13,132 | 16,057 | 23,492 | 30,753 | 36,016 | 45,643 | 61,872 | +29.5% | |
| 1,223 | 833 | 2,737 | 4,086 | 2,257 | 3,288 | 4,607 | +24.7% | |
| TOTAL ASSETS | 14,355 | 16,890 | 26,229 | 34,839 | 38,273 | 48,930 | 66,479 | +29.1% |
| 8,777 | 9,266 | 12,203 | 19,405 | 31,870 | 41,219 | 66,185 | +40.0% | |
| 3,950 | 3,748 | 11,879 | 16,714 | 9,297 | 13,738 | 17,563 | +28.2% | |
| TOTAL LIABILITIES | 12,727 | 13,014 | 24,083 | 36,118 | 41,167 | 54,957 | 83,748 | +36.9% |
| 1,628 | 3,876 | 2,146 | 1,279 | 2,893 | 6,026 | 17,269 | nmf | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 3,446 | 3,748 | 11,879 | 16,714 | 12,864 | 17,581 | 22,435 | +36.6% |
| Cash & Equivalents | 485 | 343 | 2,169 | 1,346 | 353 | 338 | 6,565 | +54.4% |
| Net Debt | 2,961 | 3,405 | 9,710 | 15,368 | 12,510 | 17,243 | 15,871 | +32.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →